
Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Treatment with protease inhibitors could result in HIV-associated neurocognitive diseases.

Top articles of the week on Specialty Pharmacy Times.

Manufacturers will present clinical trial results at the upcoming HIV medical meeting.

Gut antibody imbalance may impact immune response to HIV.

For patients with HIV, liver disease is a major cause of morbidity and mortality.

Macrophages disable protective protein, leaving an open window for HIV infection.

Social media can identify behavioral trends and attitudes relevant to the risk of infection with HIV.

Pro-inflammatory cervicovaginal bacteria increased HIV risk more than 4-fold in women.

Recreational drug use has been established as a risk factor for HIV acquisition, and many patients will find lifestyle modification—eschewing recreational drug use—difficult.

While nephrotoxicity associated with TDF has been well documented, prospective studies in HIV patients have been lacking.

February 7 marks National Black HIV/AIDS Awareness Day, which promotes awareness of HIV and AIDS and the disparity in care between African Americans in the United States compared to individuals of different races.

African American women account for 62% of women diagnosed with HIV.

Study examines whether sharing HIV status has an impact on depression or anxiety symptoms.

Top articles of the week from Specialty Pharmacy Times.

Prevention programs, HIV testing, and easier access to treatment are all areas that need to be addressed.

Adults who have HIV are more likely to develop diabetes than the general population, a study published in BMJ Open Diabetes Research & Care estimates.

Would federal funding cuts to the Ryan White Care Act be "devastating" to the HIV-positive population?

Gene may induce a broad-spectrum cellular response against infectious diseases.

HIV non-disclosure not found to have an adverse impact on depression or anxiety symptoms.

The new test service helps physicians assess patient’s responses to antiretroviral therapy for HBV.

Top news of the day from across the health care landscape.

Researchers at Johns Hopkins University investigated knowledge of smoking and nicotine among HIV-positive smokers in a study published online in Addictive Behaviors.

10-1074 was well-tolerated, demonstrated favorable pharmacokinetic properties, and had high antiviral activity among patients with HIV, a recent study found.

A new study, published in Psychiatric Services, reveals a missed opportunity for early HIV detection and treatment.